GSK PLC SP. ADR/2 NEW Cash Flow Reinvestment Rate
GSK PLC SP. ADR/2 NEW cash flow reinvestment rate. GSK PLC SP. ADR/2 NEW (GS70) has a Cash Flow Reinvestment Rate of 0.24x as of June 2026, reinvesting €653.00 Million (capex €653.00 Million ) from operating cash flow of €2.69 Billion. Explore how well can GSK PLC SP. ADR/2 NEW service its debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of GSK PLC SP. ADR/2 NEW (2021–2025)
Cash flow reinvestment rate of GSK PLC SP. ADR/2 NEW from 2021 to 2025. Historical reinvestment intensity for GSK PLC SP. ADR/2 NEW across 5 annual periods. Explore reinvestment intensity of GSK PLC SP. ADR/2 NEW to see what proportion of operating cash flow is directed to capital expenditures.
GSK PLC SP. ADR/2 NEW Cash Flow Reinvestment Rate by Year (2021–2025)
GSK PLC SP. ADR/2 NEW cash flow reinvestment rate by year from 2021 to 2025. Year-by-year capital reinvestment analysis for GSK PLC SP. ADR/2 NEW. For the full cash flow conversion analysis, see GS70 cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.39x | €3.00 Billion | €7.74 Billion | €2.98 Billion | ▼ -15.5% |
| 2024 | 0.46x | €3.00 Billion | €6.55 Billion | €2.98 Billion | ▲ +28.4% |
| 2023 | 0.36x | €2.42 Billion | €6.77 Billion | €2.34 Billion | ▲ +17.0% |
| 2022 | 0.31x | €2.26 Billion | €7.40 Billion | €2.26 Billion | ▼ -9.2% |
| 2021 | 0.34x | €2.67 Billion | €7.95 Billion | €2.65 Billion | — |